Treatment of facial verrucae with topical imiquimod cream in a patient with human immunodeficiency virus
Open Access
- 1 March 2000
- journal article
- case report
- Published by Medical Journals Sweden AB in Acta Dermato-Venereologica
- Vol. 80 (2) , 134-135
- https://doi.org/10.2340/0001555580136139
Abstract
Imiquimod is a recently developed imidazoquinolin heterocyclic amine that is an immune response modifier. Treatment with topical 5% imiquimod cream has shown promising results in the treatment of genital warts in immunocompetent individuals. We report here the first case of successful treatment with topical 5% imiquimod cream of facial verrucae in an individual with human immunodeficiency virus.Keywords
This publication has 0 references indexed in Scilit: